Since January 2021, 28 health care companies — led by the biotech sector but including health tech and services players — have filed to go public but have yet to IPO, data provided by Renaissance Capital shows.
Why it matters: Besides speaking to today's chilly public market landscape, we could see this cohort of companies pivot to alternative strategic actions or exit opportunities.
/2022/07/19/1658242781304.gif?w=3840)
